Please provide your email address to receive an email when new articles are posted on . Relapse/treatment failure rates did not differ between a low and high dose of prednisolone. The higher dose did ...
PORTLAND, Ore.--(BUSINESS WIRE)--Sparrow Pharmaceuticals today announced that it presented new data from its ongoing Phase 2 clinical trial of its HSD-1 inhibitor, clofutriben (referred to SPI-62 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback